Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tracy Rosales"'
Autor:
Divya Bezwada, Nicholas P. Lesner, Bailey Brooks, Hieu S. Vu, Zheng Wu, Ling Cai, Stacy Kasitinon, Sherwin Kelekar, Feng Cai, Arin B. Aurora, McKenzie Patrick, Ashley Leach, Rashed Ghandour, Yuanyuan Zhang, Duyen Do, Jessica Sudderth, Dennis Dumesnil, Sara House, Tracy Rosales, Alan M. Poole, Yair Lotan, Solomon Woldu, Aditya Bagrodia, Xiaosong Meng, Jeffrey A. Cadeddu, Prashant Mishra, Ivan Pedrosa, Payal Kapur, Kevin D. Courtney, Craig R. Malloy, Vitaly Margulis, Ralph J. DeBerardinis
Publikováno v:
bioRxiv
SummaryMost kidney cancers display evidence of metabolic dysfunction1–4but how this relates to cancer progression in humans is unknown. We used a multidisciplinary approach to infuse13C-labeled nutrients during surgical tumour resection in over 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6d2448d68a99890c9685f4d79bf794
https://doi.org/10.1101/2023.02.06.527285
https://doi.org/10.1101/2023.02.06.527285
Autor:
Juan De los Santos-Jiménez, Tracy Rosales, Bookyung Ko, José A. Campos-Sandoval, Francisco J. Alonso, Javier Márquez, Ralph J. DeBerardinis, José M. Matés
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 531
Most tumor cells can use glutamine (Gln) for energy generation and biosynthetic purposes. Glutaminases (GAs) convert Gln into glutamate and ammonium. In humans, GAs are encoded by two genes: GLS and GLS2. In glioblastoma, GLS is commonly overexpresse
Autor:
Akash K. Kaushik, Amy Tarangelo, Lindsey K. Boroughs, Mukundan Ragavan, Yuanyuan Zhang, Cheng-Yang Wu, Xiangyi Li, Kristen Ahumada, Jui-Chung Chiang, Vanina T. Tcheuyap, Faeze Saatchi, Quyen N. Do, Cissy Yong, Tracy Rosales, Christina Stevens, Aparna D. Rao, Brandon Faubert, Panayotis Pachnis, Lauren G. Zacharias, Hieu Vu, Feng Cai, Thomas P. Mathews, Giannicola Genovese, Barbara S. Slusher, Payal Kapur, Xiankai Sun, Matthew Merritt, James Brugarolas, Ralph J. DeBerardinis
Publikováno v:
Science advances. 8(50)
Targeting metabolic vulnerabilities has been proposed as a therapeutic strategy in renal cell carcinoma (RCC). Here, we analyzed the metabolism of patient-derived xenografts (tumorgrafts) from diverse subtypes of RCC. Tumorgrafts from VHL -mutant cle
Autor:
Akash K. Kaushik, Lindsey K. Burroughs, Amy Tarangelo, Mukundan Ragavan, Cheng-Yang Wu, Xiangyi Li, Kristen Ahumada, Vanina T. Tcheuyap, Faeze Saatchi, Quyen N Do, Cissy Yong, Tracy Rosales, Christina Stevens, Aparna Rao, Brandon Faubert, Panayotis Pachnis, Lauren G. Zacharias, Hieu Vu, Feng Cai, Thomas P. Mathews, Barbara Slusher, Payal Kapur, Xiankai Sun, Matthew Merritt, James Brugarolas, Ralph J. DeBerardinis
Targeting metabolic vulnerabilities has been proposed as a therapeutic strategy in renal cell carcinoma (RCC). Here, we analyzed metabolism in patient-derived xenografts (tumorgrafts) from diverse forms of RCC. Tumorgrafts fromVHL-mutant clear cell R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c3e71b3cc3495a852e6fb3de5ccb7c0
https://doi.org/10.1101/2022.10.31.514397
https://doi.org/10.1101/2022.10.31.514397